Oregon Health and Science University Knight Cancer Institute is a clinical research site located in Portland, Oregon, United States 97239.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Oregon Health and Science University Knight Cancer Institute has participated in 4 clinical trials with 1 currently active.
Therapeutic areas: Postoperative Ileus, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.
Sponsors: Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA), Miltenyi Biomedicine GmbH, Taiho Oncology, Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Oregon Health and Science University Knight Cancer Institute has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Oregon Health and Science University Knight Cancer Institute has 4 clinical trials on record, with 1 currently active. Their work covers Postoperative Ileus, Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma.
Yes — Oregon Health and Science University Knight Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.